AbCellera to Report Second Quarter 2022 Financial Results on August 9, 2022
AbCellera (Nasdaq: ABCL) will report its second quarter 2022 financial results on August 9, 2022, with an earnings conference call at 2:00 p.m. PT. Investors can access the webcast via the company's Investor Relations website. AbCellera is a technology firm specializing in antibody development, collaborating with various drug developers to enhance drug discovery and reduce costs. Further details about the company can be found on its official website.
- Collaboration with various drug developers enhances revenue potential.
- Innovative technology in antibody development positions AbCellera favorably in the market.
- None.
A live audio webcast of the earnings conference may be accessed through a link that will be posted on AbCellera’s Investor Relations website. A replay will be available through the same link following the conference call.
About
AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce cost, and tackle the toughest problems in drug development. For more information, please visit www.abcellera.com.
Source:
View source version on businesswire.com: https://www.businesswire.com/news/home/20220712005059/en/
Inquiries
Media:
Business Development:
Investor Relations:
Source:
FAQ
When will AbCellera announce its second quarter 2022 earnings?
What time is AbCellera's earnings conference call?
How can I access AbCellera's earnings call webcast?